
Ryan Specialty (RYAN) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
690.2M
Net Income
-4.4M
-0.64%
EPS (Diluted)
$-0.22
Balance Sheet Metrics
Total Assets
9.9B
Total Liabilities
8.8B
Shareholders Equity
1.1B
Debt to Equity
8.35
Cash Flow Metrics
Operating Cash Flow
-197.8M
Free Cash Flow
-159.6M
Revenue & Profitability Trend
Ryan Specialty Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.5B | 2.1B | 1.7B | 1.4B | 1.0B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 1.9B | 1.6B | 1.3B | 1.1B | 793.5M |
Other Operating Expenses | 15.0M | 10.4M | 5.1M | 44.9M | 32.3M |
Total Operating Expenses | 2.0B | 1.6B | 1.3B | 1.2B | 825.8M |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 158.4M | 119.5M | 104.8M | 79.4M | 47.2M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 272.6M | 237.9M | 179.2M | 61.6M | 79.5M |
Income Tax | 42.6M | 43.4M | 15.9M | 4.9M | 9.0M |
Effective Tax Rate % | 15.6% | 18.3% | 8.9% | 8.0% | 11.3% |
Net Income | 229.9M | 194.5M | 163.3M | 56.6M | 70.5M |
Net Margin % | 9.1% | 9.4% | 9.5% | 4.0% | 6.9% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $0.78 | $0.53 | $0.57 | $-0.07 | $0.64 |
EPS (Diluted) | $0.71 | $0.52 | $0.52 | $-0.07 | $0.64 |
Basic Shares Outstanding | 120781234 | 114359968 | 112437825 | 109894548 | 106488770 |
Diluted Shares Outstanding | 120781234 | 114359968 | 112437825 | 109894548 | 106488770 |
Income Statement Trend
Ryan Specialty Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 540.2M | 838.8M | 992.7M | 387.0M | 312.7M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 20.2M | 3.2B | 2.6B | 2.4B | 2.0B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 6.8B | 3.9B | 3.1B | 3.2B | 3.1B |
Intangible Assets | 1.5B | 610.7M | 486.4M | 573.9M | 604.8M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 9.6B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | - | - | - | - |
Short-term Debt | 73.8M | 56.7M | 53.3M | 42.3M | 39.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 3.4B | 2.1B | 2.1B | 1.6B | 1.6B |
Deferred Tax Liabilities | 39.9M | - | 562.0K | 631.0K | 577.0K |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 8.6B | - | - | - | - |
Equity | |||||
Common Stock | 261.0K | 261.0K | 259.0K | 259.0K | 0 |
Retained Earnings | 122.9M | 114.4M | 54.0M | -7.1M | 0 |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.1B | 979.6M | 817.8M | 594.8M | 71.1M |
Key Metrics | |||||
Total Debt | 3.5B | 2.2B | 2.2B | 1.7B | 1.7B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Ryan Specialty Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 229.9M | 194.5M | 163.3M | 56.6M | 70.5M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 79.0M | 69.7M | 77.5M | 67.5M | 10.8M |
Working Capital Changes | -49.7M | 37.0M | -82.8M | -30.2M | -41.5M |
Operating Cash Flow | 314.2M | 350.0M | 201.3M | 147.9M | 63.3M |
Investing Activities | |||||
Capital Expenditures | - | - | - | 0 | 0 |
Acquisitions | -1.7B | -446.7M | 0 | -108.9M | -741.5M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -1.7B | -446.5M | -7.4M | -448.2M | -756.0M |
Financing Activities | |||||
Share Repurchases | -2.1M | 0 | 0 | -1.0B | -52.6M |
Dividends Paid | -80.2M | 0 | 0 | 0 | -50.1M |
Debt Issuance | 2.5B | 0 | 394.0M | 0 | 1.7B |
Debt Repayment | -1.3B | -16.5M | -16.5M | -17.7M | -904.0M |
Financing Cash Flow | 1.2B | -12.6M | 338.1M | 429.3M | 391.1M |
Free Cash Flow | 467.9M | 447.4M | 320.5M | 263.7M | 122.9M |
Net Change in Cash | -227.6M | -109.0M | 532.0M | 129.0M | -301.6M |
Cash Flow Trend
Ryan Specialty Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
147.55
Forward P/E
26.71
Price to Book
12.30
Price to Sales
5.66
PEG Ratio
18.69
Profitability Ratios
Profit Margin
2.02%
Operating Margin
23.84%
Return on Equity
16.98%
Return on Assets
3.48%
Financial Health
Current Ratio
1.01
Debt to Equity
309.01
Beta
0.64
Per Share Data
EPS (TTM)
$0.40
Book Value per Share
$4.80
Revenue per Share
$22.09
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ryan | 15.6B | 147.55 | 12.30 | 16.98% | 2.02% | 309.01 |
Fidelity National | 16.2B | 15.13 | 2.05 | 13.75% | 7.90% | 54.14 |
Axis Capital | 7.3B | 8.99 | 1.30 | 15.07% | 14.30% | 24.11 |
First American | 6.6B | 35.65 | 1.29 | 3.84% | 2.90% | 51.53 |
MGIC Investment | 6.3B | 9.00 | 1.24 | 14.85% | 62.58% | 12.52 |
Essent | 6.2B | 9.10 | 1.10 | 12.94% | 56.36% | 8.72 |
Financial data is updated regularly. All figures are in the company's reporting currency.